File Download

There are no files associated with this item.

Supplementary

Conference Paper: Vonoprazan-based dual and triple therapy versus bismuth-based quadruple therapy as first-line therapy for Helicobacter pylori in China: a three-arm, randomized clinical trial

TitleVonoprazan-based dual and triple therapy versus bismuth-based quadruple therapy as first-line therapy for Helicobacter pylori in China: a three-arm, randomized clinical trial
Authors
Cheung, KSLyu, TDeng, ZHan, SNi, LWu, JTan, JTNg, HYLeung, WKSeto, WK
Issue Date18-May-2024
Persistent Identifierhttp://hdl.handle.net/10722/340014

 

DC FieldValueLanguage
dc.contributor.authorCheung, KS-
dc.contributor.authorLyu, T-
dc.contributor.authorDeng, Z-
dc.contributor.authorHan, S-
dc.contributor.authorNi, L-
dc.contributor.authorWu, J-
dc.contributor.authorTan, JT-
dc.contributor.authorNg, HY-
dc.contributor.authorLeung, WK-
dc.contributor.authorSeto, WK-
dc.date.accessioned2024-03-11T10:41:01Z-
dc.date.available2024-03-11T10:41:01Z-
dc.date.issued2024-05-18-
dc.identifier.urihttp://hdl.handle.net/10722/340014-
dc.languageeng-
dc.relation.ispartofDigestive Disease Week 2024 (18/05/2024-21/05/2024, , , Washington, DC, USA)-
dc.titleVonoprazan-based dual and triple therapy versus bismuth-based quadruple therapy as first-line therapy for Helicobacter pylori in China: a three-arm, randomized clinical trial-
dc.typeConference_Paper-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats